VRXA insider buying and SEC filings, explained
Veraxa Biotech Holding AG · CIK 2079109
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$108K
Insiders who bought
2
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 27–28, 2026 | Purchase (code P) | Marc Gruninger (Director) bought 10,000 shares between Oct 27 and Oct 28 at about $0.9983 ($10K), reported as a purchase (code P). New position of 10,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 29, 2026, 4:52 PM ET |
| Oct 20, 2026 | Purchase (code P) | Christoph Samuel Ziegler (Director) bought 30,000 shares at $1.09 ($33K), reported as a purchase (code P). Holdings up 378% to 37,932 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 21, 2026, 4:10 PM ET |
| Aug 27, 2026 | Purchase (code P) | Oliver Rolf Baumann (Director) bought 50,000 shares indirectly at $1.50 ($75K), reported as a purchase (code P). Indirect holdings up 1% to 5,773,618 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 31, 2026 |
| Aug 27, 2026 | Purchase (code P) | Christoph Rudiger Antz (CEO and Director) bought 5,000 shares at $1.53 ($8K), reported as a purchase (code P). New position of 5,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 31, 2026 |
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow VRXA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.